[Cell therapy for Epstein-Barr virus-associated disease].
Kuzushima
Kiyotaka
K
Division of Immunology, Aichi Cancer Center Research Institute.
D002051:Burkitt Lymphoma / Q000628:therapy* / Q000821:virology*; D064987:Cell- and Tissue-Based Therapy / Q000379:methods; D002908:Chronic Disease; D020031:Epstein-Barr Virus Infections / Q000628:therapy* / Q000821:virology; D004854:Herpesvirus 4, Human; D006689:Hodgkin Disease / Q000628:therapy* / Q000821:virology*; D006801:Humans; D016867:Immunocompromised Host; D008232:Lymphoproliferative Disorders / Q000628:therapy* / Q000821:virology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology